Close

Protalix BioTherapeutics (PLX) to Present New ELELYSO Data at EWGGD 2014

June 27, 2014 7:06 AM EDT Send to a Friend
Protalix BioTherapeutics (NYSE: PLX) announced that new clinical data on ELELYSO (taliglucerase alfa) will be presented at the European Working ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login